ReP USP - Resultado da busca

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal, v. 21, p. 2033-2041, 2000Tradução . . Acesso em: 29 ago. 2024.
APA
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. (2000). The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal, 21, 2033-2041.
NLM
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 2000 ; 21 2033-2041.[citado 2024 ago. 29 ]
Vancouver
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 2000 ; 21 2033-2041.[citado 2024 ago. 29 ]

ReP